A. Introduction
- Parturition is act of giving birth to the young
- Labor is the physiologic process by which the fetus is expelled from the uterus
- Placenta derived maternal corticotropin releasing hormone (CRH) levels determine term
- Expulsion of fetus from uterus requires synchronized myometrial contractions
- Events associated with labor normally occur prior to spontaneous rupture of fetal membranes
- Preterm births occur in 5-15% of pregnancies
- Apgar scores at 1 and 5 minutes are the best prognostic factors for normal and preterm births [12]
B. Parturition [1]
- Placenta produces CRH and secretes most of it into maternal circulation
- During pregnancy, CRH levels increase exponential through positive feed-forward loop
- CRH stimulates pituitary corticotropin (ACTH) production
- ACTH stimulates adrenal cortex to release cortisol (and stimulates DHEA-S production)
- Glucocorticoids further stimulate production of CRH by placenta
- Estrogen, progesterone and nitric oxide inhibit placental CRH production
- CRH availability is modulated by circulating CRH-binding protein (CRH-BP)
- Towards the end of pregnancy, CRH-BP levels fall, increasing available CRH
- Exponential increases in CRH signal end of pregnancy (parturition)
- In an individual woman, rate of change of CRH level is best predictor of onset of labor
- Dehydroepiandrosterone sulfate (DHEA-S) is converted to estrogen
- CRH levels also rise in the fetus
- CRH in the fetus stimulates fetal cortisol production
- This stimulates lung maturation, with production of surfactant A and phospholipids
- Surfactant A and phospholipids are inflammatory, stimulating myometrial contractions
- Combination of maternal and fetal events driven by CRH stimulate myometrial activity
- Myometrial Activity
- Uterus is normally in queiescent phase during pregnancy
- Quiescent phase composed of irregular, long-lasting contractions
- At onset of labor, regular, high-intensity, long-lasting contractions occur
- Umbilical Cord
- Clamping and cutting the umbilical cord is performed after the baby appears
- ~25-60% of (54-160mL) of combined fetal-placetnal circulation found in placenta
- Early clamping of umbilical cord associated with reduction in 20-40mL/kg of blood and ~30mg of iron versus delayed clamping
- Delayed clamping (2 minutes after birth) in full-term neonates associated with improved hematologic measures and iron status, reduced risk of anemia, in neonate [4]
C. Stages and Phases of Labor
- Stage I
- Phase 0: Functional quiescence of myometrium
- Phase I: Latent, mild, irregular contractions - to "ripen" cervix
- Phase II: Active, accelerated dilation begins at 3-4 cm
- Phase III: Deceleration Phase to full dilation at10 cm
- Stage II - from full cervical dilation to delivery of baby
- Stage III - up to delivery of the placenta
D. Biochemistry of Labor
- Phase 0
- Uterus maintained in state of functional quiescence
- Various inhibitors have been identified including:
- Progesterone
- Prostacyclin
- Relaxin
- Nitric oxide
- Parathyroid hormone related peptide (PTHRP)
- Various other molecules have a role
- Phase 1
- Uterus undergoes activation
- This is mainly due to effects of CRH on downstream events estrogen
- Drop in functional progesterone levels stimulates myometrial activation
- Prostaglandins E and F stimulate myometrial contractions
- Characterized by increased expression of contractile proteins and ion channels
- Increase in connexin 43, a gap junction protein, leads to coordinated myometrial function
- Phase 2
- Stimulation phase with increased uterine activity
- Prostaglandins E2 and F2alpha
- Oxytocin
- Phase 3
- Involution of uterus after delivery
- Oxytocin plays a major role
- Thrombin may also have a role
- Cervical Softening ("Ripening")
- Due to migration of inflammatory infiltrate into cervix
- Release of metalloproteases that degrade collagen
- Junction between decidua and and fetal membranesw breaks dosn
- Adhesive protein, fetal fibronectin, enters vaginal fluid
- Presence of fetal fibronectin in vaginal fluid predicts imminent delivery
- Inflammation due to infection can precipitate myometrial activation/contractions at any time during the pregnancy
E. Fetal Movement During Labor
- Engagement
- Descent
- Flexion of neck
- Rotation (usually to Occipital-Anterior or OA)
- Extension
- External Rotation (Restitution then Shoulder Rotation)
- Expulsion (usually anterior shoulder first)
F. Determinants of Labor (the 3 "P's")
- Power - Contractions
- Passenger - Size of Baby
- Passage - Size of pelvic opening
G. Abnormal Labor
- Normal Labor takes ~12-14 hours for P0 (Para zero)
- Precipitous Labor
- Protracted Labor
- Prolonged Latent Phase - >20 hours for P0 or >14 hours in Pt/n
- Protracted Active Phase - <1.2 cm/hr for P0 or <1.5cm/hr in Pt
- Arrested Active Phase - no dilatation for >2 hours of fialure of descent for >1 hour
- Arrest or Failure of Descent
- Preterm Labor
- Labor prior to 37 weeks' gestation
- Occurs in ~8% of births
- Accounts for >85% of perinatal complications and death
- May reflect breakdown in mechanisms responsible for maintaining uterine quiescence
- May also be caused by overwhelming levels of uterine stimulating activities
- Does not appear to be caused by Trichomonas vaginalis infection [15]
- Pathophysiology of Preterm Labor / Birth [6]
- Four well described pathways, which may be initiated months before preterm labor
- Excessive myometrial and fetal membrane overdistention
- Decidual hemorrhage
- Precocious fetal endocrine activation
- Intrauterine infection or other inflammation
- Combinations of these processes may accelerate the process further
- Diagnosis of Preterm Labor / Parturition [6]
- Uterine contractions preterm are a poor predictor of actual labor
- Cervical dilatation, softening, shortening, can occur without imminent labor
- Preterm "labor" resolves spontaneously in ~30% of women
- Fetal fibronectin (vaginal fluid) and ultrasonography may accurately predict preterm labor
- Effects of Anesthesia on Labor
- Combination spinal/epidural anesthesia does not increase rate of cesarean deliveries
- Epidural anesthesia slighly increases length of labor but not rate of complications [8]
- Neonatal outcomes are better after epidural than parenteral opioids [8]
- Abnormal labor may contribute to intracranial injuries to the neonate [10]
- Prolonged labor (especially in developing countries) increases risk of vesicovaginal fistula [3]
H. Anesthesia and Analgesia [9]
- ~60% of women chose analgesia for labor
- Epidural or spinal-epidural anesthesia usually selected
- Epidural Anesthesia
- achieved with catheter into lumbar epidural space usually between L3 and L4
- Local anesthetic AND/OR opioid are used
- Epidural analgesia initiated early in labor (cervix <4cm dilated) increases C-section risk [5]
- Early intrathecal analgesia followed by later epidural analgesia does not affect C-section rates and is better tolerated than systemic opiate analgesia [5]
- Combined Epidural-Spinal Anesthesia
- Has recently become popular
- Single dose opioid injected into subarachnoid space
- This allows rapid relief of pain with essentially no motor effects
- Epidural anesthesia also given
- Most studies show no effect of epidural anesthesia on C-section rates
I. Induction of Labor
- Indications for Active Induction
- >42 weeks pregnancy (most common)
- Fetal Distress / Maternal Illness:
- Intrauterine growth retartdation
- Chronic placental insufficiency
- Preeclampsia
- Diabetes Mellitus
- Premature Rupture of Membranes (PROM)
- Infection (Chorioamnionitis)
- Rh Disease
- Active induction reduces postpartum hemorrhage and blood loss [6,14]
- Non-Pharmacologic Methods
- Dilateria (laminaria)
- Dilapan - synthetic cervical dilator
- Transcutaneous electrical nerve stimulator units (TENS)
- Walking has no effect on labor or delivery outcomes or types [7]
- Pharmacologic Methods
- Use of medical agents is considered "active" management of labor
- Oxytocin - 10IU intravenous (IV) or intramuscular; most commonly used
- Misoprostal - PGE2 analog 600µg orally
- Oxytocin slightly more effective and fewer side effects than misoprostal [14]
- Dinoprostone, PGE2 given intravaginally, induces labor
- Ergometrine or Syntometrine - may be used in combination with oxytocin
- Investigational: Mifepristone (RU 486)
- Pharmacologic induction is contraindicated in women with a history of Cesarean Section [13]
- Active versus Expectant Management of Labor
- Active intervention was oxytocic agent within 2 minutes of birth
- Active management also included immediate cutting and clamping of cord
- Delivery of placenta by controlled cord traction or maternal effort in active group
- Expectant management only included delivery of placenta by maternal effort
- Postpartum hemorrhage occurred in 16.5% of expectant and 6.8% of active groups
- Therefore, need to treat 10 women actively to prevent one postpartum hemorrhage
- Posture (supine or upright) had no effect on hemorrhage
- Routine episiotomy for vaginal delivery of no overall benefit, may be deleterious [17]
J. Indications for Cesarean (C-) Section
- Infection: Herpes Simplex Virus, Group B streptococcus, HIV
- Arrested Labor (usually with failed induction attempt)
- Breech Presentation [11]
- Abnormal Maternal or Fetal Anatomy - cephalo-pelvic dysproportion
- Extremely large fetus
- Fetal Distress
- Placenta Previa
- Entangled Umbilical Cord
- Vasa Previa
- Previous C-Section [13,16]
- Increased risk of uterine rupture in women with previous C-section delivering vaginally
- Pharmacologic induction after previous C-section greatly increases rupture risk
- Absolute risk of death associated with trial of labor after C-section is low
- However, risk of death much higher with trial of labor versus planned C-section in women with previous C-section [16]
K. Postpartum Fever
- Common obstetric complication
- Much more common in C-section patients than vaginal delivery
- Most C-section patients receive antibiotic prophylaxis
- Common Causes
- Endometritis (may progress to pelvic abscess)
- Urinary Tract Infection (UTI)
- Wound Infection (episiotomy usually)
- Phlebitis, Thrombosis
- Mastitis
- Endometritis
- Most common cause of postpartum fever
- ~2% of vaginal deliveries, 5-50% of C-sections
- Fever, uterine tenderness, foul smelling discharge
- Group B streptococcus (S. agalactiae) is common cause of fever <48 hours of delivery
- May progress or form pelvic abscess
- Mastitis
- Breast engorgement common postpartum
- Low grade fever may occur early after delivery (without infection)
- True mastitis occus 2-3 weeks postpartum
- Associated with cellulitis over breast area and fever to at least 39°C (102.2°F)
- Staphylococcus is most common infection; antibiotic therapy is indicated
- May be confused with inflammatory breast cancer
- Patients should be encouraged to continue breast feeding
- Empiric Therapy
- Fever >38°C in first 10 days postpartum
- Evaluate for common causes above
- Routine blood tests including complete blood count; urinalysis
- Empiric Antibiotics: Gentamicin + Clindamycin/Oxacillin or Ampicillin-Sulbactam
- Consider adding ampicillin or vancomycin to cover Enterococcus
- Ultrasound evaluation to rule out pelvic abscess, other pathology
- Consider mammography if inflammatory breast cancer suspected
- Persistant fevers despite antibiotic therapy - suspect septic pelvic thrombophlebitis
- Septic pelvic thrombophlebitis is treated with heparin
Resources
Apgar Score
References
- Smith R. 2007. NEJM. 356(3):271
- Norwitz ER, Robinson JN, Challis JRG. 1999. NEJM. 341(9):660
- Wall LL. 2006. Lancet. 368(9542):1201
- Hutton EK and Hassan ES. 2007. JAMA. 297(11):1241
- Wong CA, Scavone BM, Peaceman AM, et al. 2005. NEJM. 352(7):655
- Simhan HN and Canritis SN. 2007. NEJM. 357(15):477
- Bloom SL, McIntire DD, Kelly MA, et al. 1998. NEJM. 339(2):76
- Halper SH, Leighton BL, Ohlsson A, et al. 1998. JAMA. 280(24):2105
- Elzschig HK, Lieberman ES, Camann WR. 2003. NEJM. 348(4):319
- Towner D, Castro MA, Eby-Wilkens E, Gilbert WM. 1999. NEJM. 341(23):1709
- Hannah ME, Hannah WJ, Hewson SA, et al. 2000. Lancet. 356(9239):1375
- Casey BM, McIntire DD, Leveno KJ. 2001. NEJM. 344(7):467
- Lydon-Rochelle M, Holt VL, Easterling TR, Martin DP. 2001. NEJM. 345(1):3
- Gulmezoglu AM, Villar J, Ngoc NTN, et al. 2001. Lancet. 358(9283):689
- Klebanoff MA, Carey JC, Hauth JC, et al. 2001. NEJM. 345(7):487
- Smith GCS, Pell JP, Cameron AD, Dobbie R. 2002. JAMA. 287(20):2684
- Hartmann K, Viswanathan M, Palmieri R, et al. 2005. JAMA. 293(17):2141